AbCellera Biologics Inc.

14.70-0.6900-4.48%Vol 1.38M1Y Perf -74.94%
Jul 27th, 2021 14:06 DELAYED
BID14.70 ASK14.73
Open15.35 Previous Close15.39
Pre-Market- After-Market-
 - -%  - -
Target Price
45.25 
Analyst Rating
— — 0.00
Potential %
206.57 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     61.73
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★★     89.65
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap3.98B 
Earnings Rating
Price Range Ratio 52W %
0.33 
Earnings Date
12th Aug 2021

Today's Price Range

14.5115.45

52W Range

14.5171.91

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.81%
1 Month
-25.80%
3 Months
-47.80%
6 Months
-
1 Year
-74.94%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ABCL14.70-0.6900-4.48
AAPL146.20-2.7900-1.87
GOOG2 705.91-86.9800-3.11
MSFT284.14-4.9100-1.70
XOM57.52-0.9600-1.64
WFC45.040.03000.07
JNJ172.320.45000.26
FB366.01-6.4500-1.73
GE13.070.15001.16
JPM151.59-0.0600-0.04
Earnings HistoryEstimateReportedSurprise %
Q01 20210.370.370.00
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th Aug 2021
Estimated EPS Next Report0.09
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.38M
Shares Outstanding270.93M
Trades Count9.03K
Dollar Volume19.74M
Avg. Volume1.35M
Avg. Weekly Volume1.31M
Avg. Monthly Volume1.76M
Avg. Quarterly Volume1.69M

AbCellera Biologics Inc. (NASDAQ: ABCL) stock closed at 15.39 per share at the end of the most recent trading day (a -2.53% change compared to the prior day closing price) with a volume of 1.91M shares and market capitalization of 3.98B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 174 people. AbCellera Biologics Inc. CEO is Carl L.G. Hansen.

The one-year performance of AbCellera Biologics Inc. stock is -74.94%, while year-to-date (YTD) performance is %. ABCL stock has a five-year performance of %. Its 52-week range is between 14.51 and 71.91, which gives ABCL stock a 52-week price range ratio of 0.33%

AbCellera Biologics Inc. currently has a PE ratio of 19.00, a price-to-book (PB) ratio of 4.47, a price-to-sale (PS) ratio of 9.67, a price to cashflow ratio of 32.20, a PEG ratio of 2.32, a ROA of 18.11%, a ROC of 20.95% and a ROE of 21.36%. The company’s profit margin is 55.41%, its EBITDA margin is 77.70%, and its revenue ttm is $431.24 Million , which makes it $1.59 revenue per share.

Of the last four earnings reports from AbCellera Biologics Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.09 for the next earnings report. AbCellera Biologics Inc.’s next earnings report date is 12th Aug 2021.

The consensus rating of Wall Street analysts for AbCellera Biologics Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for AbCellera Biologics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AbCellera Biologics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

AbCellera Biologics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 33.06, ATR14 : 1.21, CCI20 : -104.88, Chaikin Money Flow : -0.19, MACD : -2.07, Money Flow Index : 17.02, ROC : -16.90, RSI : 25.27, STOCH (14,3) : 7.32, STOCH RSI : 0.00, UO : 40.24, Williams %R : -92.68), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AbCellera Biologics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

AbCellera Biologics Inc.

AbCellera Biologics Inc is a biotechnology company. The company develops antibodies to treat highly infectious diseases and various other types of diseases.

CEO: Carl L.G. Hansen

Telephone: +1 604 559-9005

Address: 2215 Yukon Street, Vancouver V5Y 0A1, BC, CA

Number of employees: 174

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

64%36%

Bearish Bullish

63%38%

News

Stocktwits